삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

방사선종양학과 유정일 교수

진료분야
대장암, 췌장암, 담도암, 간암, 위암, 육종, 특수방사선치료, 양성자치료
진료일정 09 月
날짜
일
01
월
02
화
03
수
04
목
05
금
06
토
07
일
08
월
09
화
10
수
11
목
12
금
13
토
14
일
15
월
16
화
17
수
18
목
19
금
20
토
21
일
22
월
23
화
24
수
25
목
26
금
27
토
28
일
29
월
30
오전
오후
진료일정 10 月
날짜
화
01
수
02
목
03
금
04
토
05
일
06
월
07
화
08
수
09
목
10
금
11
토
12
일
13
월
14
화
15
수
16
목
17
금
18
토
19
일
20
월
21
화
22
수
23
목
24
금
25
토
26
일
27
월
28
화
29
수
30
목
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2018.02 성균관대학교 대학원 의학과 박사 졸업
2012.02 충북대학교 대학원 의학과 석사 졸업
2005.02 차의과대학교 졸업

경력

경력
2023.03 ~현재 삼성서울병원 방사선종양학과 부교수
2019.03 ~ 2023.02 삼성서울병원 방사선종양학과 조교수
2017.03 ~ 2019.02 삼성서울병원 방사선종양학과 전임대우 조교수
2016.03 ~ 2017.02 삼성서울병원 방사선종양학과 진료조교수
2015.03 ~ 2016.02 삼성서울병원 방사선종양학과 임상전임강사
2013.05 ~ 2015.02 삼성서울병원 방사선종양학과 임상강사
2010.04 ~ 2012.04 경기도 연천군 공중보건의사
2006.03 ~ 2010.02 삼성서울병원 방사선종양학과 전공의 과정 수료
2005.02 ~ 2006.02 삼성서울병원 인턴 과정 수료

학회활동

학회활동
2013.05 ~ 현재 Korean Society for Radiation Oncology (KOSRO)
2013.05 ~ 현재 Member
2013.05 ~ 현재 Member
2010.03 ~ 현재 Korean Medical Association (KMA)
2005.03 ~ 현재 Member

수상이력

수상이력
2015.06 제7회 대한암학회 로슈 학술상 수상
2014.05 제8회 대한간암학회 정기학술대회 구연상
2014.05 한국암학술재단 장학생 수상
2013.10 제31회 대한방사선종양학회 정기학술대회 전시상
2011.10 제29회 대한방사선종양학회 정기학술대회 전시상
2008.10 제4회 대한방사선종양학회 젊은 연구자상 수상
2007.10 제3회 대한방사선종양학회 젊은 연구자상 수상
논문
  • CANCER RES TREAT 2024 10.4143/crt.2023.886 Combined High-Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma: A Multi-institutional Cohort Study Im, JH; Il Yu, J; Kim, TH; Kim, TG; Kim, JW; Seong, J
    View PubMed
  • ANTICANCER RES 2024 10.21873/anticanres.17029 Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma Seo, SH; Yu, JI; Park, HC; Yoo, GS; Choi, MS; Rhim, H; Lee, MW; Han, S; Park, B; Shim, JS
    View PubMed
  • CLIN TRANSL RAD ONCO 2024 10.1016/j.ctro.2024.100732 Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy Kim, K; Park, HC; Yu, JI; Park, JO; Hong, JY; Lee, KT; Lee, KH; Lee, JK; Park, JK; Heo, JS; Shin, SH; Min, JH; Kim, K; Han, IW
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.616 Risk Factors for Distant Metastasis in Extrahepatic Bile Duct Cancer after Curative Resection (KROG 1814) Park, Y; Kim, TH; Kim, K; Yu, JI; Jung, W; Seong, J; Kim, WC; Choi, JH; Chang, AR; Jeong, BK; Kim, BH; Kim, TG; Kim, JH; Park, HJ; Shin, HS; Im, JH; Chie, EK
    View PubMed
  • RADIOTHER ONCOL 2023 10.1016/j.radonc.2023.109841 External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion Yu, JI; Park, HC; Shin, H; Park, H; Shin, SW; Cho, SK; Hyun, D; Shin, J; Goh, MJ; Choi, MS; Park, B; Yoon, SM; Jung, JH
    View PubMed
  • FRONT SURG 2023 10.3389/fsurg.2023.1209698 Effect of pre-operative radiation therapy on surgical outcome in retroperitoneal sarcoma Jo, SJ; Park, SSW; Yoo, GS; Kim, KD; Lim, SH; Kim, J; Kim, MJ; Yu, JI; Park, JB; Lee, KW
    View PubMed
  • CLIN MOL HEPATOL 2023 10.3350/cmh.2022.0404 Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective Goh, MJ; Sinn, DH; Kim, JM; Lee, MW; Hyun, DH; Il Yu, J; Hong, JY; Choi, MS
    View PubMed
  • LIVER CANCER 2023 10.1159/000529635 Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors Goh, MJ; Park, HC; Yu, JI; Kang, WS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Sinn, DH; Choi, MS
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2021.1527 A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer Jo, H; Kim, ST; Lee, JY; Park, SH; Park, JO; Park, YS; Lim, HY; Il Yu, J; Park, HC; Choi, DH; Park, Y; Cho, YB; Huh, JW; Yun, SH; Kim, HC; Lee, WY; Kang, WK
    View PubMed
  • J GASTRIC CANCER 2023 10.5230/jgc.2023.23.e11 Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach Kim, TH; Kim, IH; Kang, SJ; Choi, M; Kim, BH; Eom, BW; Kim, BJ; Min, BH; Choi, CI; Shin, CM; Tae, CH; Gong, CS; Kim, DJ; Cho, AEH; Gong, EJ; Song, GJ; Im, HS; Ahn, HS; Lim, H; Kim, HD; Kim, JJ; Il Yu, J; Lee, JW; Park, JY; Kim, JH; Song, KD; Jung, MKY; Jung, MR; Son, SY; Park, SH; Kim, SJ; Lee, SH; Kim, TY; Bae, WK; Koom, WS; Jee, Y; Kim, YM; Kwak, Y; Park, YS; Han, HS; Nam, SY; Kong, SH
    View PubMed
  • J GASTRIC CANCER 2023 10.5230/jgc.2023.23.e1 Role of Adjuvant Radiotherapy in Gastric Cancer Il Yu, J
    View PubMed
  • CANCER MED-US 2023 10.1002/cam4.5530 Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers Kim, JE; Kim, H; Kim, B; Chung, HG; Chung, HH; Kim, KM; Kim, SH; Jeong, WK; Kim, YK; Min, JH; Heo, JS; Han, IW; Shin, SH; Park, HC; Yu, JI; Park, JO; Kim, ST; Hong, JY; Lee, SH; Lee, KH; Lee, JK; Lee, KT; Jang, KT; Park, JK
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.960527 Clinical implication and management of rectal cancer with clinically suspicious lateral pelvic lymph node metastasis: A radiation oncologist's perspective Yoo, GS; Park, HC; Yu, JI
    View PubMed
  • RADIOTHER ONCOL 2022 10.1016/j.radonc.2022.09.003 A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases Kim, K; Il Yu, J; Park, HC; Yoo, GS; Lim, D; Noh, JM; Jeong, WK
    View PubMed
  • INT J MOL SCI 2022 10.3390/ijms232112923 Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm Lee, H; Ryu, HS; Park, HC; Yu, JI; Yoo, GS; Choi, C; Nam, H; Lee, JJB; Do, IG; Han, D; Ha, SY
    View PubMed
  • CANCERS 2022 10.3390/cancers14194556 The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer Shin, H; Yu, JI; Park, HC; Yoo, GS; Cho, S; Park, JO; Lee, KT; Lee, KH; Lee, JK; Park, JK; Heo, JS; Han, IW; Shin, SH
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.928119 Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017 Bae, BK; Park, HC; Yu, JI; Yoo, GS; Sinn, DH; Choi, MS; Oh, JH
    View PubMed
  • BIOMEDICINES 2022 10.3390/biomedicines10071565 Clinical Significance of Preoperative Hematological Parameters in Patients with D2-Resected, Node-Positive Stomach Cancer Park, JS; Yu, JI; Lim, DH; Nam, H; Kim, YI; Lee, J; Kang, WK; Park, SH; Kim, ST; Hong, JY; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.332 Chronological Analysis of Acute Hematological Outcomes after Proton and Photon Beam Craniospinal Irradiation in Pediatric Brain Tumors Yoo, GS; Yu, JI; Cho, S; Han, Y; Oh, Y; Lim, DH; Nam, HR; Lee, JW; Sung, KW; Shin, HJ
    View PubMed
  • CANCERS 2022 10.3390/cancers14092081 The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment Bae, BK; Park, HC; Yoo, GS; Choi, MS; Oh, JH; Yu, JI
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.888755 Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis Yu, JI; Kang, W; Yoo, GS; Goh, MJ; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Hong, JY; Lim, HY; Park, B; Park, HC
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-11592-3 Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer Yu, JI; Yoo, GS; Park, HC; Choi, DH; Lee, WY; Yun, SH; Kim, HC; Cho, YB; Huh, JW; Park, YA; Shin, JK; Park, JO; Kim, ST; Park, YS; Lee, J; Kang, WK; Lim, HY; Hong, JY
    View PubMed
  • ANN SURG ONCOL 2022 10.1245/s10434-022-11688-w ASO Visual Abstract: Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative Intent Surgery and/or Ablation for Metastatic Rectal Cancer Yu, JI; Yoo, GS; Park, HC; Choi, DH; Lee, WY; Yun, SH; Kim, HC; Cho, YB; Huh, JW; Park, YA; Shin, JK; Park, JO; Kim, ST; Park, YS; Lee, J; Kang, WK; Lim, HY; Hong, JY
    View PubMed
  • PANCREATOLOGY 2021 10.1016/j.pan.2021.05.004 Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches Kim, SW; Il Yu, J; Lee, IJ; Park, MS; Hwang, SH; Yang, HK; Jeong, WK; Lee, SS; Kim, JH; Choi, JY; O, JH; Lee, JW; Lee, SW; Hong, SM; Jang, KT; Lee, KB; Kim, H; Choi, MY; Lee, WJ
    View PubMed
  • EUR J CANCER 2021 10.1016/j.ejca.2021.07.045 Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14) Kim, K; Il Yu, J; Jung, W; Kim, TH; Seong, J; Kim, WC; Choi, JH; Park, Y; Jeong, BK; Kim, BH; Kim, TG; Kim, JH; Park, HJ; Shin, HS; Im, JH; Heo, JS; Park, JO; Jang, JY; Oh, DY; Woo, SM; Lee, WJ; Chie, EK
    View PubMed
  • FRONT IMMUNOL 2021 10.3389/fimmu.2021.701668 Prognostic Impact of Sarcopenia and Radiotherapy in Patients With Advanced Gastric Cancer Treated With Anti-PD-1 Antibody Kim, N; Yu, JI; Lim, DH; Lee, J; Kim, ST; Hong, JY; Kang, WK; Jeong, WK; Kim, KM
    View PubMed
  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • ANN ONCOL 2021 10.1016/j.annonc.2020.11.017 A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial Park1, SH; Lim, DH; Sohn, TS; Lee, J; Zang, DY; Kim, ST; Kang, JH; Oh, SY; Hwang, IG; Ji, JH; Shin, DB; Yu, JI; Kim, KM; An, JY; Choi, MG; Lee, JH; Kim, S; Hong, JY; Park, JO; Park, YS; Lim, HY; Bae, JM; Kang, WK
    View PubMed
  • CELLS 2021 10.3390/cells10030554 Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells Choi1, C; Lee, GH; Son, A; Yoo, GS; Yu, JI; Park, HC
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-82177-5 Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma Yu1, JI; Park, HC; Yoo, GS; Choi, C; Choi, MS; Nam, H; Baek, SY; Park, M
    View PubMed
  • CANCERS 2021 10.3390/cancers13010059 Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression Analyses Park1, JS; Il Yu, J; Lim, D; Nam, H; Kim, YI; Lee, J; Kang, WK; Park, SH; Kim, ST; Hong, JY; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM
    View PubMed
  • CANCER IMMUNOL IMMUN 2020 10.1007/s00262-020-02794-3 Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab Kim1, N; Yu, JI; Park, HC; Yoo, GS; Choi, C; Hong, JY; Lim, HY; Lee, J; Choi, MS; Lee, JE; Kim, K
    View PubMed
  • RADIOTHER ONCOL 2020 10.1016/j.radonc.2020.07.043 Effect of baseline sarcopenia on adjuvant treatment for D2 dissected gastric cancer Analysis of the ARTIST phase III trial Yu1, JI; Choi, C; Lee, J; Kang, WK; Park, SH; Kim, ST; Hong, JY; Kim, S; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM; Kim, KM; Han, H; Kim, K; Nam, H; Lim, DH
    View PubMed
  • CANCERS 2020 10.3390/cancers12092395 Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter? Yoo1, GS; Il Yu, J; Park, HC; Hyun, D; Jeong, WK; Lim, HY; Choi, MS; Ha, SY
    View PubMed
  • ANN SURG ONCOL 2020 10.1245/s10434-020-08408-7 Regional Lymph Node Metastasis of Scalp Angiosarcoma A Detailed Clinical Observation Study of 40 Cases Kang1, Y; Bae, J; Choi, S; Jang, KT; Yu, J; Hong, JY; Lim, SY; Jeong, HS
    View PubMed
  • TUMORI 2020 10.1177/0300891620937795 Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy Cho1, WK; Yu, JI; Park, HC; Lim, DH; Kim, TH; Chie, EK
    View PubMed
  • INT J COLORECTAL DIS 2020 10.1007/s00384-020-03701-z Determining whether postoperative chemoradiotherapy is required in patients with pathologic T3N0 rectal cancer with negative resection margin Baek1, JY; Yu, JI; Park, HC; Choi, DH; Yoo, GS; Lee, WY; Yun, SH; Cho, YB; Park, YA; Kim, HC; Nam, H
    View PubMed
  • CANCERS 2020 10.3390/cancers12051300 Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma Yu1, JI; Park, HC; Yoo, GS; Paik, SW; Choi, MS; Kim, HS; Sohn, I; Nam, H
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.261 Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer Yoo1, GS; Park, HC; Yu, JI; Choi, DH; Cho, WK; Park, YS; Park, JO; Lim, HY; Kang, WK; Lee, WY; Kim, HC; Yun, SH; Cho, YB; Park, YA; Song, KD; Kim, SH; Ha, SY
    View PubMed
  • CANCERS 2020 10.3390/cancers12040943 Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer Yu1, JI; Park, HC; Lee, J; Choi, C; Kang, WK; Park, SH; Kim, ST; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM; Kim, KM; Han, H; Kim, K; Kim, S; Lim, DH
    View PubMed
  • Cancer Med 2019 10.1002/cam4.2570 Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma Yu1, JI; Lee, SJ; Lee, J; Lim, HY; Paik, SW; Yoo, GS; Choi, C; Park, HC
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-50594-2 Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma Ha1, SY; Yu, JI; Choi, C; Kang, S; Joh, JW; Paik, SW; Kim, S; Kim, M; Park, HC; Park, CK
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.423 Korean First Prospective Phase II Study, Feasibility of Prone Position in Postoperative Whole Breast Radiotherapy: A Dosimetric Comparison Chung1, Y; Yu, JI; Park, W; Choi, DH
    View PubMed
  • ANTICANCER RES 2019 10.21873/anticanres.13785 Clinical Outcomes and the Role of Adjuvant Concurrent Chemoradiation Therapy in D2-resected LN-positive Young Patients (<= 45 Years) With Gastric Cancer Yu1, JI; Lim, DH; Lee, J; Kang, WK; Park, SH; Park, JO; Lim, HY; Kim, ST; Kim, S; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM; Kim, HS; Ahn, S
    View PubMed
  • ACTA RADIOL 2019 10.1177/0284185118805253 Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI Song1, SH; Jeong, WK; Choi, D; Kim, YK; Park, HC; Yu, JI
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.401 Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node-Positive Gastric Cancer Treated with Different Adjuvant Protocols Yu1, JI; Lim, D; Lee, J; Kang, WK; Park, SH; Park, JO; Park, YS; Lim, HY; Kim, ST; Lee, SJ; Kim, S; Sohn, TS; Lee, JH; An, JY; Choi, MG; Rae, JM; Yoo, H; Kim, K
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.424 Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418) Yoo1, GS; Park, W; Yu, JI; Choi, DH; Kim, YJ; Shin, KH; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, J
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0218049 Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction Choi1, C; Son, A; Lee, GH; Shin, SW; Park, S; Ahn, SH; Chung, Y; Yu, JI; Park, HC
    View PubMed
  • ANN SURG 2019 10.1097/SLA.0000000000002582 Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemoradiotherapy and Resection for Rectal Cancer Jang1, JH; Kim, HC; Huh, JW; Park, YA; Cho, YB; Yun, SH; Lee, WY; Yu, JI; Park, HC; Park, YS; Park, JO
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0210730 Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
    View PubMed
  • RADIOTHER ONCOL 2018 10.1016/j.radonc.2018.07.002 Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer Yu1, JI; Lim, DH; Lee, J; Kang, WK; Park, SH; Park, JO; Park, YS; Lim, HY; Kim, ST; Lee, SJ; Kim, S; Sohn, TS; Lee, JH; An, JY; Choi, MG; Bae, JM; Kim, HS; Ahn, S
    View PubMed
  • ASIA-PAC J CLIN ONCO 2018 10.1111/ajco.12769 Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma Cho1, CW; Lee, KW; Park, H; Kim, HJ; Park, JB; Choi, YL; Yu, JI; Lee, SJ; Choi, DI; Kim, SJ
    View PubMed
  • INT J COLORECTAL DIS 2018 10.1007/s00384-018-3131-6 Indistinguishable T2/T3-N0 rectal cancer on rectal magnetic resonance imaging: comparison of surgery-first and neoadjuvant chemoradiation therapy-first strategies Kim1, JG; Song, KD; Cha, DI; Kim, H; Yu, JI
    View PubMed
  • ANTICANCER RES 2018 10.21873/anticanres.12808 Treatment of Naive HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection Versus TACE Followed by Radiotherapy Yu1, JI; Choi, GS; Lim, DH; Lee, E; Joh, JW; Kwon, CHD; Kim, JM; Kim, S; Woo, SY; Paik, SW; Park, HC
    View PubMed
  • WORLD J GASTROENTERO 2018 10.3748/wjg.v24.i28.3090 Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives Yoo1, GS; Yu, JI; Park, HC
    View PubMed
  • ANTICANCER RES 2018 10.21873/anticanres.12498 Effectiveness and Safety of Tissue Expander for Adjuvant Helical Tomotherapy in Curatively Resected Retroperitoneal Sarcoma Yu1, JI; Lim, DH; Park, HC; Jung, SH; Jeon, SJ; Nam, H; Kim, B; Kim, SJ; Park, JB
    View PubMed
  • AM J CLIN ONCOL-CANC 2018 10.1097/COC.0000000000000224 Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma Choi1, Y; Lim, DH; Yu, JI; Jo, K; Nam, DH; Seol, HJ; Lee, JI; Kong, DS; Suh, YL; Nam, H
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22511 Elevated CEA is associated with worse survival in recurrent rectal cancer Cho1, WK; Choi, DH; Park, HC; Park, W; Yu, JI; Park, YS; Park, JO; Lim, HY; Kang, WK; Kim, HC; Cho, YB; Yun, SH; Lee, WY
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-15165-3 Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation Il Yu1, J; Choi, C; Shin, SW; Son, A; Lee, GH; Kim, SY; Park, HC
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.21775 Prognostic group stratification and nomogram for predicting overall survival in patients who received radiotherapy for abdominal lymph node metastasis from hepatocellular carcinoma: a multi-institutional retrospective study (KROG 15-02) Kim1, Y; Park, HC; Yoon, SM; Kim, TH; Lee, J; Choi, J; Yu, JI; Park, JH; Kim, JH; Park, JW; Seong, J
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.508 Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418) Kim1, YJ; Park, W; Ha, B; Park, B; Joo, J; Kim, TH; Park, IH; Lee, KS; Lee, ES; Shin, KH; Kim, H; Il Yu, J; Choi, DH; Huh, SJ; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, JY
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.382 Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study Kim1, H; Park, W; Yu, JI; Choi, DH; Huh, SJ; Kim, YJ; Lee, ES; Lee, KS; Kang, HS; Park, IH; Shin, KH; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, J
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.20529 Stereotactic ablative body radiotherapy for spinal metastasis from hepatocellular carcinoma: its oncologic outcomes and risk of vertebral compression fracture Yoo1, GS; Park, HC; Il Yu, J; Lim, DH; Cho, WK; Lee, E; Jung, SH; Han, Y; Kim, ES; Lee, SH; Eoh, W; Park, SJ; Chung, SS; Lee, CS; Lee, JH
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-12469-2 Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area Yu1, JI; Choi, C; Ha, SY; Park, CK; Kang, SY; Joh, JW; Paik, SW; Kim, S; Kim, M; Jung, SH; Park, HC
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.17072 Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial Yu1, JI; Park, HC; Jung, SH; Choi, C; Shin, SW; Cho, SK; Sinn, DH; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Yoo, BC; Sahinbas, H; Paik, SW
    View PubMed
  • TUMORI 2017 10.5301/tj.5000666 Clinical outcomes of salvage chemoradiotherapy for locally recurrent biliary tract cancer Yu1, JI; Park, HC; Lim, DH; Park, JO; Park, YS; Kim, ST; Choi, SH; Choi, DW; Han, IW; Heo, JS
    View PubMed
  • Liver Transpl. 2017 Apr;23(4):545-551. doi: 10.1002/lt.24729. The possibility of radiotherapy as downstaging to living donor liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus Choi JY11, Yu JI2, Park HC2, David Kwon CH3, Kim JM3, Joh JW3, Choi GS3, Park JB3, Kim SJ3, Lee SH4, Cho WT5, Lee KW3, Na BG3, Oh DK3, Lee N3, Cho CW3, Lee S3, Lee SK3.
    View PubMed
  • Jpn J Clin Oncol. 2017 Apr 1;47(4):328-333. doi: 10.1093/jjco/hyw205. Predictive factors of gastroduodenal bleeding after postoperative radiotherapy in biliary tract cancer Lee J11, Lim DH1, Park HC1, Yu JI1, Choi DW2, Choi SH2, Heo JS2.
    View PubMed
  • Liver Int. 2017 Feb;37(2):308-309. doi: 10.1111/liv.13278. Response to Is radiotherapy the best option for treating hepatocellular carcinoma with PVTT? Im JH11, Yoon SM2, Park HC3,4, Kim JH2, Yu JI3,4, Kim TH5, Kim JW6, Nam TK7, Kim K8, Jang HS9, Kim JH10, Kim MS11, Yoon WS12, Jung I13, Seong J1.
    View PubMed
  • Liver Int. 2017 Jan;37(1):90-100. doi: 10.1111/liv.13191. Epub 2016 Jul 12. Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area Im JH11, Yoon SM2, Park HC3,4, Kim JH2, Yu JI3,4, Kim TH5, Kim JW6, Nam TK7, Kim K8, Jang HS9, Kim JH10, Kim MS11, Yoon WS12, Jung I13, Seong J1.
    View PubMed
  • J Radiat Res. 2017 Jan;58(1):155-163. doi: 10.1093/jrr/rrw089. Epub 2016 Sep 26. Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study Yu JI11, Park HC2,3, Ahn YC1,3, Gao XS4, Wang JJ5, Zeng ZC6, Ito Y7, Ohno T8, Nishimura Y9.
    View PubMed
  • Oncotarget. 2017 Jan 3;8(1):1796-1804. doi: 10.18632/oncotarget.12882. Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418) Kim H11, Park W2, Yu JI2, Choi DH2, Huh SJ2, Kim YJ3, Lee ES3, Lee KS3, Kang HS3, Park IH3, Shin KH4, Kim K5, Park KR5, Kim YB6, Ahn SJ7, Lee JH8, Kim JH9, Chun M10, Lee HS11, Kim JS12, Lee JY13.
    View PubMed
  • Cancer Res Treat. 2017 Jan;49(1):61-69. doi: 10.4143/crt.2016.097. Epub 2016 Jun 13. Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07) Cha H11,2, Park HC2,3, Yu JI2, Kim TH4, Nam TK5, Yoon SM6, Yoon WS7, Kim JW8, Kim MS9, Jang HS10, Choi Y11, Kim JH12, Kay CS13, Jung I14, Seong J1.
    View PubMed
  • Radiother Oncol. 2016 Feb;118(2):408-15. doi: 10.1016/j.radonc.2015.11.019. Epub 2016 Jan 28. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study. Yu JI1, Park JW, Park HC, Yoon SM, Lim do H, Lee JH, Lee HC, Kim SW and Kim JH.
    View PubMed
  • Radiat Oncol J. 2016 Mar;34(1):34-44. doi: 10.3857/roj.2016.34.1.34. Epub 2016 Mar 30. Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer. Yu JI1, Park HC, Choi DH, Noh JM, Oh D, Park JS, Chang JH, Kim ST, Lee J, Park SH, Park JO, Park YS, Lim HY and Kang WK.
    View PubMed
  • Cancer Res Treat. 2016 Apr;48(2):574-82. doi: 10.4143/crt.2015.076. Epub 2015 Jul 17. Do Biliary Complications after Hypofractionated Radiation Therapy in Hepatocellular Carcinoma Matter? Yu JI1, Park HC, Lim do H and Paik SW.
    View PubMed
  • Radiat Oncol J. 2016 Mar;34(1):64-75. doi: 10.3857/roj.2016.34.1.64. Epub 2016 Mar 30. A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images. Jung SH1, Yu JI, Park HC, Lim do H and Han Y.
    View PubMed
  • Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11. Limited Supraclavicular Radiation Field in Breast Cancer With >/= 10 Positive Axillary Lymph Nodes. Yu JI1, Park W, Choi DH, Huh SJ, Nam SJ, Kim SW, Lee JE, Kil WH, Im YH, Ahn JS, Park YH and Cho EY.
    View PubMed
  • Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial. . Yu JI1, Park HC, Oh D, Noh JM, Jung SH, Kim HY, Shin SW, Cho SK, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW and Yoo BC.
    View PubMed
  • Oncotarget. 2016 Sep 20;7(38):62676-62686. doi: 10.18632/oncotarget.10445. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy Yu JI11, Lee H2, Park HC1, Choi DH1, Choi YL3, Do IG4, Kim HC5, Lee WY5, Yun SH5, Cho YB5, Huh JW5, Park YA6, Park YS6, Park JO6, Kim ST6, Park W1.
    View PubMed
  • World J Gastroenterol. 2016 Aug 14;22(30):6851-63. doi: 10.3748/wjg.v22.i30.6851. Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis Yu JI11, Park HC1.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):1102-9. doi: 10.4143/crt.2015.207. Epub 2015 Dec 2. Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014 Yu JI11, Park HC1,2, Ahn YC1,2, Chung Y1, Koom WS3, Song SY4.
    View PubMed
  • Medicine (Baltimore). 2016 Jul;95(28):e4123. doi: 10.1097/MD.0000000000004123. Clinical outcomes of tissue expanders on adjuvant radiotherapy of resected retroperitoneal sarcoma Yu JI11, Lim do H, Park HC, Nam H, Kim BK, Kim SJ, Park JB.
    View PubMed
  • Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11. Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • Radiother Oncol. 2016 Feb;118(2):408-15. doi: 10.1016/j.radonc.2015.11.019. Epub 2016 Jan 28. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study Yu JI11, Park JW2, Park HC3, Yoon SM4, Lim do H1, Lee JH5, Lee HC6, Kim SW7, Kim JH2.
    View PubMed
  • Clin Breast Cancer. 2015 Aug;15(4):e197-204. doi: 10.1016/j.clbc.2015.03.006. Epub 2015 Mar 24. Prognostic Modeling in Pathologic N1 Breast Cancer Without Elective Nodal Irradiation After Current Standard Systemic Management. Yu JI1, Park W, Choi DH, Huh SJ, Nam SJ, Kim SW, Lee JE, Kil WH, Im YH, Ahn JS, Park YH and Cho EY
    View PubMed
  • Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments. Yu JI1, Park W, Choi DH, Huh SJ, Nam SJ, Kim SW, Lee JE, Kil WH, Im YH, Ahn JS, Park YH and Cho EY.
    View PubMed
  • Cancer Res Treat. 2015 Dec 2. doi: 10.4143/crt.2015.207. Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014. Yu JI1, Park HC, Ahn YC, Chung Y, Koom WS and Song SY.
    View PubMed
  • Radiat Oncol J. 2015 Dec;33(4):276-83. doi: 10.3857/roj.2015.33.4.276. Epub 2015 Dec 30. Treatment outcome of hepatic re-irradiation in patients with hepatocellular carcinoma. Seol SW1, Yu JI, Park HC, Lim do H, Oh D, Noh JM, Cho WK and Paik SW.
    View PubMed
  • Am J Clin Oncol. 2015 Aug 11. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma. Choi Y1, Lim DH, Yu JI, Jo K, Nam DH, Seol HJ, Lee JI, Kong DS, Suh YL and Nam H.
    View PubMed
  • Radiother Oncol. 2015 Oct;117(1):171-7. doi: 10.1016/j.radonc.2015.08.009. Epub 2015 Aug 20. Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist's view of the ARTIST randomized phase III trial. Yu JI1, Lim do H, Ahn YC, Lee J, Kang WK, Park SH, Park JO, Park YS, Lim HY, Kim ST, Kim S, Sohn TS, Choi MG, Bae JM and Nam H.
    View PubMed
  • Radiat Oncol J. 2015 Sep;33(3):217-25. doi: 10.3857/roj.2015.33.3.217. Epub 2015 Sep 30. Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma. Lee E1, Kim TG, Park HC, Yu JI, Lim do H, Nam H, Lee H and Lee JH.
    View PubMed
  • Radiat Oncol J. 2015 Dec;33(4):301-9. doi: 10.3857/roj.2015.33.4.301. Epub 2015 Dec 30. Prognostic factors in breast cancer with extracranial oligometastases and the appropriate role of radiation therapy. Yoo GS1, Yu JI, Park W, Huh SJ and Choi DH.
    View PubMed
  • Radiat Oncol J. 2015 Dec;33(4):337-43. doi: 10.3857/roj.2015.33.4.337. Epub 2015 Dec 30. The first private-hospital based proton therapy center in Korea; status of the Proton Therapy Center at Samsung Medical Center. Chung K1, Han Y, Kim J, Ahn SH, Ju SG, Jung SH, Chung Y, Cho S, Jo K, Shin EH, Hong CS, Shin JS, Park S, Kim DH, Kim HY, Lee B, Shibagaki G, Nonaka H, Sasai K, Koyabu Y, Choi C, Huh SJ, Ahn YC, Pyo HR, Lim do H, Park HC, Park W, Oh DR, Noh JM, Yu JI, Song S, Lee JE, Lee B and Choi DH.
    View PubMed
  • Clin Breast Cancer. 2015 Oct;15(5):353-61.e1-2. doi: 10.1016/j.clbc.2015.01.008. Epub 2015 Feb 7. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06). Yu JI1, Choi DH, Huh SJ, Cho EY, Kim K, Chie EK, Ha SW, Park IA, Ahn SJ, Lee JS, Shin KH, Kwon Y, Kim YB, Suh CO, Koo JS, Kim JH, Jeong BG, Kim IA, Lee JH and Park W.
    View PubMed
  • Radiat Oncol J. 2015 Jun;33(2):83-8. doi: 10.3857/roj.2015.33.2.83. Epub 2015 Jun 30. Can we omit prophylactic inguinal nodal irradiation in anal cancer patients? Kim H1, Park HC, Yu JI, Choi DH, Ahn YC, Kim ST, Park JO, Park YS and Kim HC.
    View PubMed
  • World J Surg Oncol. 2015 Jul 29;13:227. doi: 10.1186/s12957-015-0637-z. Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study Gil E11, Joh JW2, Park HC3, Yu JI4, Jung SH4, Kim JM5.
    View PubMed
  • Med Phys. 2015 May;42(5):2626-37. doi: 10.1118/1.4916663. Preclinical investigation for developing injectable fiducial markers using a mixture of BaSO4 and biodegradable polymer for proton therapy Ahn SH11, Gil MS2, Lee DS2, Han Y3, Park HC3, Sohn JW4, Kim HY5, Shin EH5, Yu JI3, Noh JM3, Cho JS3, Ahn SH3, Choi DH3.
    View PubMed
  • Clin Breast Cancer. 2015 Apr;15(2):e105-15. doi: 10.1016/j.clbc.2014.10.002. Epub 2014 Oct 12. Unique Characteristics and Failure Patterns of Metaplastic Breast Cancer in Contrast to Invasive Ductal Carcinoma: A Retrospective Multicenter Case-Control Study (KROG 13-07) Yu JI11, Choi DH2, Huh SJ1, Ahn SJ3, Lee JS4, Shin KH5, Kwon Y5, Kim YB6, Suh CO6, Kim JH7, Cho J8, Kim IA9, Lee JH10, Park W1.
    View PubMed
  • J Breast Cancer. 2015 Mar;18(1):50-6. doi: 10.4048/jbc.2015.18.1.50. Epub 2015 Mar 27. Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer Yu JI11, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.
    View PubMed
  • Radiother Oncol. 2015 Mar;114(3):384-8. doi: 10.1016/j.radonc.2015.02.016. Epub 2015 Mar 4. The effects of radiation therapy on height and spine MRI characteristics in children with neuroblastoma Yu JI11, Lim do H2, Jung SH1, Sung KW3, Yoo SY4, Nam H5.
    View PubMed
  • Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma. Cho JY1, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW and Yoo BC.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):814-21. doi: 10.1016/j.ijrobp.2014.03.020. The role of diffusion-weighted magnetic resonance imaging in the treatment response evaluation of hepatocellular carcinoma patients treated with radiation therapy. Yu JI1, Park HC, Lim do H, Choi Y, Jung SH, Paik SW, Kim SH, Jeong WK and Kim YK.
    View PubMed
  • Dig Dis. 2014;32(6):755-63. doi: 10.1159/000368018. Epub 2014 Oct 29. Considerations for radiation therapy in hepatocellular carcinoma: the radiation oncologists' perspective. 1,Yu JI and Park HC.
    View PubMed
  • Radiat Oncol J. 2014 Jun;32(2):77-83. doi: 10.3857/roj.2014.32.2.77. Epub 2014 Jun 30. Prognostic and predictive value of liver volume in colorectal cancer patients with unresectable liver metastases. Park JS1, Park HC, Choi DH, Park W, Yu JI, Park YS, Kang WK and Park JO.
    View PubMed
  • Cancer Res Treat. 2014 Oct;46(4):348-57. doi: 10.4143/crt.2013.142. Epub 2014 Jul 16. Multicenter validation study of a prognostic index for portal vein tumor thrombosis in hepatocellular carcinoma. Yu JI1, Yoon SM, Park HC, Kim JH, Kim TH, Park JW, Seong J, Lee IJ, Jang HS, Kay CS, Kim CY, Chie EK, Kim JH, Kim MS and Choi YM.
    View PubMed
  • Tumori. 2014 Nov-Dec;100(6):645-51. doi: 10.1700/1778.19270. Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: aspects of gastroduodenal complications. Yu JI1, Cho JY, Park HC, Lim do H, Gwak GY and Paik SW.
    View PubMed
  • Tumori. 2013 Mar-Apr;99(2):164-71. doi: 10.1700/1283.14187. Predictive factors for Child-Pugh score elevation in hepatocellular carcinoma patients treated with conformal radiation therapy: dose-volume histogram analysis. Yu JI1, Park HC, Lim do H and Park WY.
    View PubMed
  • Oncology. 2013;85(1):14-20. doi: 10.1159/000352002. Epub 2013 Jun 21. Prophylactic supraclavicular radiotherapy after surgery in high-risk n1 breast cancer. Yu JI1, Park W, Shin KH, Lee NK, Choi DH and Huh SJ.
    View PubMed
  • Radiat Oncol J. 2013 Jun;31(2):72-80. doi: 10.3857/roj.2013.31.2.72. Epub 2013 Jun 30. The reasonable timing of the adjuvant radiotherapy in the treatment of uterine carcinosarcoma according to the surgical intent: suggestion based on progression patterns. Yu JI1, Choi DH, Huh SJ, Park W, Oh D and Bae DS.
    View PubMed
  • J Korean Med Sci. 2012 Jul;27(7):736-43. doi: 10.3346/jkms.2012.27.7.736. Epub 2012 Jun 29. Scheduled interval trans-catheter arterial chemoembolization followed by radiation therapy in patients with unresectable hepatocellular carcinoma. Yu JI1, Park HC, Lim do H, Kim CJ, Oh D, Yoo BC, Paik SW, Kho KC and Lee JH.
    View PubMed
  • Radiat Oncol J. 2011 Sep;29(3):214-7. doi: 10.3857/roj.2011.29.3.214. Epub 2011 Sep 30. Variable uterine uptake of FDG in adenomyosis during concurrent chemoradiation therapy for cervical cancer. Yu JI1, Huh SJ, Kim YI, Kim TJ and Park BK.
    View PubMed
  • J Korean Med Sci. 2011 Aug;26(8):1014-22. doi: 10.3346/jkms.2011.26.8.1014. Epub 2011 Jul 27. Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy. Yu JI1, Park HC, Lim do H, Park W, Yoo BC, Paik SW, Koh KC and Lee JH.
    View PubMed
  • Breast. 2010 Jun;19(3):231-7. doi: 10.1016/j.breast.2010.01.020. Epub 2010 Mar 20. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study. Yu JI1, Choi DH, Park W, Huh SJ, Cho EY, Lim YH, Ahn JS, Yang JH and Nam SJ.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1135-41. doi: 10.1016/j.ijrobp.2009.09.037. Epub 2010 Mar 16. Determining which patients require irradiation of the supraclavicular nodal area after surgery for N1 breast cancer. Yu JI1, Park W, Huh SJ, Choi DH, Lim YH, Ahn JS, Yang JH and Nam SJ.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):507-12. doi: 10.1016/j.ijrobp.2009.07.1706. Epub 2010 Jan 7. Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma. Yu JI1, Nam H, Ahn YC, Kim WS, Park K and Kim SJ.
    View PubMed
  • Int J Dermatol. 2009 Jul;48(7):784-6. doi: 10.1111/j.1365-4632.2009.04029.x. Scleredema adultorum of Buschke associated with a carcinoid tumor. Yu JI1, Park W, Lee KK and Park W.
    View PubMed

해당하는 결과가 없습니다.